1	PTTG	_	NN	_	_	2	NMOD	_	_
2	overexpression	_	NN	_	_	3	VMOD	_	_
3	promotes	_	VBZ	_	_	0	ROOT	_	_
4	lymph	_	NN	_	_	5	NMOD	_	_
5	node	_	NN	_	_	6	NMOD	_	_
6	metastasis	_	NN	_	_	3	VMOD	_	_
7	in	_	IN	_	_	6	NMOD	_	_
8	human	_	JJ	_	_	12	NMOD	_	_
9	esophageal	_	JJ	_	_	12	NMOD	_	_
10	squamous	_	JJ	_	_	12	NMOD	_	_
11	cell	_	NN	_	_	12	NMOD	_	_
12	carcinoma	_	NN	_	_	7	PMOD	_	_
13	.	_	.	_	_	3	P	_	_
		
1	Human	_	JJ	_	_	5	NMOD	_	_
2	pituitary	_	JJ	_	_	5	NMOD	_	_
3	tumor	_	NN	_	_	5	NMOD	_	_
4	transforming	_	NN	_	_	5	NMOD	_	_
5	gene	_	NN	_	_	9	NMOD	_	_
6	(	_	(	_	_	7	P	_	_
7	PTTG	_	NN	_	_	5	PRN	_	_
8	)	_	)	_	_	7	P	_	_
9	overexpression	_	NN	_	_	10	VMOD	_	_
10	correlates	_	VBZ	_	_	0	ROOT	_	_
11	with	_	IN	_	_	10	VMOD	_	_
12	metastasis	_	NN	_	_	11	PMOD	_	_
13	in	_	IN	_	_	10	VMOD	_	_
14	multiple	_	JJ	_	_	15	NMOD	_	_
15	tumors	_	NNS	_	_	13	PMOD	_	_
16	,	_	,	_	_	10	P	_	_
17	and	_	CC	_	_	10	COORD	_	_
18	yet	_	RB	_	_	24	VMOD	_	_
19	its	_	PRP$	_	_	21	NMOD	_	_
20	molecular	_	JJ	_	_	21	NMOD	_	_
21	mechanisms	_	NNS	_	_	24	VMOD	_	_
22	of	_	IN	_	_	21	NMOD	_	_
23	action	_	NN	_	_	22	PMOD	_	_
24	remain	_	VBP	_	_	17	CONJ	_	_
25	elusive	_	JJ	_	_	24	VMOD	_	_
26	.	_	.	_	_	10	P	_	_
		
1	We	_	PRP	_	_	2	VMOD	_	_
2	detected	_	VBD	_	_	0	ROOT	_	_
3	PTTG	_	NN	_	_	4	NMOD	_	_
4	overexpression	_	NN	_	_	2	VMOD	_	_
5	in	_	IN	_	_	2	VMOD	_	_
6	66	_	CD	_	_	7	NMOD	_	_
7	%	_	NN	_	_	5	PMOD	_	_
8	(	_	(	_	_	7	PRN	_	_
9	111	_	CD	_	_	11	DEP	_	_
10	of	_	IN	_	_	11	DEP	_	_
11	169	_	CD	_	_	8	DEP	_	_
12	)	_	)	_	_	8	P	_	_
13	of	_	IN	_	_	7	NMOD	_	_
14	primary	_	JJ	_	_	23	NMOD	_	_
15	esophageal	_	JJ	_	_	18	NMOD	_	_
16	squamous	_	JJ	_	_	18	NMOD	_	_
17	cell	_	NN	_	_	18	NMOD	_	_
18	carcinoma	_	NN	_	_	23	NMOD	_	_
19	(	_	(	_	_	20	P	_	_
20	ESCC	_	NN	_	_	18	PRN	_	_
21	)	_	)	_	_	20	P	_	_
22	tumor	_	NN	_	_	23	NMOD	_	_
23	tissues	_	NNS	_	_	13	PMOD	_	_
24	by	_	IN	_	_	2	VMOD	_	_
25	in	_	FW	_	_	26	AMOD	_	_
26	situ	_	FW	_	_	27	NMOD	_	_
27	hybridization	_	NN	_	_	24	PMOD	_	_
28	.	_	.	_	_	2	P	_	_
		
1	PTTG	_	NN	_	_	2	NMOD	_	_
2	overexpression	_	NN	_	_	3	VMOD	_	_
3	correlated	_	VBD	_	_	0	ROOT	_	_
4	with	_	IN	_	_	3	VMOD	_	_
5	lymph	_	NN	_	_	7	NMOD	_	_
6	node	_	NN	_	_	7	NMOD	_	_
7	metastasis	_	NN	_	_	4	PMOD	_	_
8	(	_	(	_	_	10	P	_	_
9	P	_	NN	_	_	10	NMOD	_	_
10	<	_	NN	_	_	7	PRN	_	_
11	0.05	_	CD	_	_	10	NMOD	_	_
12	)	_	)	_	_	10	P	_	_
13	.	_	.	_	_	3	P	_	_
		
1	Ectopic	_	JJ	_	_	3	NMOD	_	_
2	PTTG	_	NN	_	_	3	NMOD	_	_
3	overexpression	_	NN	_	_	13	VMOD	_	_
4	in	_	IN	_	_	3	NMOD	_	_
5	a	_	DT	_	_	9	NMOD	_	_
6	representative	_	JJ	_	_	9	NMOD	_	_
7	ESCC	_	NN	_	_	9	NMOD	_	_
8	cell	_	NN	_	_	9	NMOD	_	_
9	line	_	NN	_	_	4	PMOD	_	_
10	,	_	,	_	_	9	P	_	_
11	EC9706	_	NN	_	_	9	APPO	_	_
12	,	_	,	_	_	9	P	_	_
13	increased	_	VBD	_	_	0	ROOT	_	_
14	in	_	FW	_	_	15	AMOD	_	_
15	vitro	_	FW	_	_	17	NMOD	_	_
16	cell	_	NN	_	_	17	NMOD	_	_
17	migration	_	NN	_	_	13	VMOD	_	_
18	and	_	CC	_	_	17	COORD	_	_
19	invasion	_	NN	_	_	18	CONJ	_	_
20	and	_	CC	_	_	13	COORD	_	_
21	promoted	_	VBD	_	_	20	CONJ	_	_
22	in	_	FW	_	_	23	AMOD	_	_
23	vivo	_	FW	_	_	25	NMOD	_	_
24	lymph	_	NN	_	_	25	NMOD	_	_
25	node	_	NN	_	_	26	NMOD	_	_
26	metastasis	_	NN	_	_	21	VMOD	_	_
27	.	_	.	_	_	13	P	_	_
		
1	Suppressing	_	JJ	_	_	3	NMOD	_	_
2	PTTG	_	NN	_	_	3	NMOD	_	_
3	expression	_	NN	_	_	6	VMOD	_	_
4	by	_	IN	_	_	3	NMOD	_	_
5	siRNA	_	NN	_	_	4	PMOD	_	_
6	decreased	_	VBD	_	_	0	ROOT	_	_
7	cell	_	NN	_	_	8	NMOD	_	_
8	motility	_	NN	_	_	6	VMOD	_	_
9	in	_	IN	_	_	6	VMOD	_	_
10	both	_	CC	_	_	14	DEP	_	_
11	PTTG-HA/EC9706	_	CD	_	_	14	NMOD	_	_
12	and	_	CC	_	_	11	COORD	_	_
13	KYSE150	_	CD	_	_	12	CONJ	_	_
14	cells	_	NNS	_	_	9	PMOD	_	_
15	.	_	.	_	_	6	P	_	_
		
1	By	_	IN	_	_	8	VMOD	_	_
2	using	_	VBG	_	_	1	PMOD	_	_
3	mass	_	NN	_	_	5	NMOD	_	_
4	spectrometric	_	NN	_	_	5	NMOD	_	_
5	analysis	_	NN	_	_	2	VMOD	_	_
6	,	_	,	_	_	8	P	_	_
7	we	_	PRP	_	_	8	VMOD	_	_
8	identified	_	VBD	_	_	0	ROOT	_	_
9	that	_	IN	_	_	8	VMOD	_	_
10	PTTG	_	NN	_	_	11	VMOD	_	_
11	up-regulated	_	VBD	_	_	9	SUB	_	_
12	S100A4	_	NN	_	_	15	NMOD	_	_
13	and	_	CC	_	_	12	COORD	_	_
14	galectin-1	_	NN	_	_	13	CONJ	_	_
15	secretion	_	NN	_	_	11	VMOD	_	_
16	and	_	CC	_	_	11	COORD	_	_
17	down-regulated	_	VBD	_	_	16	CONJ	_	_
18	tissue	_	NN	_	_	19	NMOD	_	_
19	inhibitor	_	NN	_	_	17	VMOD	_	_
20	of	_	IN	_	_	19	NMOD	_	_
21	metalloproteinase-2	_	NN	_	_	22	NMOD	_	_
22	secretion	_	NN	_	_	20	PMOD	_	_
23	to	_	TO	_	_	19	NMOD	_	_
24	the	_	DT	_	_	26	NMOD	_	_
25	culture	_	NN	_	_	26	NMOD	_	_
26	media	_	NNS	_	_	23	PMOD	_	_
27	.	_	.	_	_	8	P	_	_
		
1	PTTG	_	NN	_	_	2	VMOD	_	_
2	induced	_	VBD	_	_	0	ROOT	_	_
3	S100A4	_	NN	_	_	6	NMOD	_	_
4	and	_	CC	_	_	3	COORD	_	_
5	galectin-1	_	NN	_	_	4	CONJ	_	_
6	mRNA	_	NN	_	_	2	VMOD	_	_
7	and	_	CC	_	_	6	COORD	_	_
8	protein	_	NN	_	_	9	NMOD	_	_
9	expression	_	NN	_	_	7	CONJ	_	_
10	as	_	IN	_	_	2	VMOD	_	_
11	assessed	_	VBN	_	_	10	SUB	_	_
12	by	_	IN	_	_	11	VMOD	_	_
13	Western	_	NN	_	_	14	NMOD	_	_
14	blot	_	NN	_	_	12	PMOD	_	_
15	and	_	CC	_	_	14	COORD	_	_
16	reverse	_	JJ	_	_	17	NMOD	_	_
17	transcription-PCR	_	NN	_	_	15	CONJ	_	_
18	.	_	.	_	_	2	P	_	_
		
1	Attenuating	_	NN	_	_	3	NMOD	_	_
2	galectin-1	_	NN	_	_	3	NMOD	_	_
3	expression	_	NN	_	_	6	VMOD	_	_
4	by	_	IN	_	_	3	NMOD	_	_
5	siRNA	_	NN	_	_	4	PMOD	_	_
6	constrained	_	VBD	_	_	0	ROOT	_	_
7	PTTG-HA/EC9706	_	NN	_	_	9	NMOD	_	_
8	cell	_	NN	_	_	9	NMOD	_	_
9	motility	_	NN	_	_	6	VMOD	_	_
10	(	_	(	_	_	12	P	_	_
11	P	_	NN	_	_	12	NMOD	_	_
12	<	_	NN	_	_	9	PRN	_	_
13	0.05	_	CD	_	_	12	NMOD	_	_
14	)	_	)	_	_	12	P	_	_
15	.	_	.	_	_	6	P	_	_
		
1	PTTG	_	NN	_	_	2	VMOD	_	_
2	activated	_	VBD	_	_	0	ROOT	_	_
3	E-box	_	NN	_	_	4	NMOD	_	_
4	transcription	_	NN	_	_	2	VMOD	_	_
5	and	_	CC	_	_	2	COORD	_	_
6	induced	_	VBD	_	_	5	CONJ	_	_
7	c-Myc	_	NN	_	_	9	NMOD	_	_
8	protein	_	NN	_	_	9	NMOD	_	_
9	expression	_	NN	_	_	6	VMOD	_	_
10	in	_	IN	_	_	9	NMOD	_	_
11	EC9706	_	NN	_	_	12	NMOD	_	_
12	cells	_	NNS	_	_	10	PMOD	_	_
13	,	_	,	_	_	12	P	_	_
14	which	_	WDT	_	_	17	VMOD	_	_
15	in	_	IN	_	_	17	VMOD	_	_
16	turn	_	NN	_	_	15	PMOD	_	_
17	may	_	MD	_	_	12	NMOD	_	_
18	act	_	VB	_	_	17	VC	_	_
19	on	_	IN	_	_	18	VMOD	_	_
20	an	_	DT	_	_	22	NMOD	_	_
21	E-box	_	NN	_	_	22	NMOD	_	_
22	motif	_	NN	_	_	19	PMOD	_	_
23	within	_	IN	_	_	22	NMOD	_	_
24	the	_	DT	_	_	26	NMOD	_	_
25	galectin-1	_	NN	_	_	26	NMOD	_	_
26	promoter	_	NN	_	_	23	PMOD	_	_
27	.	_	.	_	_	2	P	_	_
		
1	Chromatin	_	NN	_	_	3	NMOD	_	_
2	immunoprecipitation	_	NN	_	_	3	NMOD	_	_
3	assays	_	NNS	_	_	5	VMOD	_	_
4	further	_	RB	_	_	5	VMOD	_	_
5	confirmed	_	VBD	_	_	0	ROOT	_	_
6	specific	_	JJ	_	_	8	NMOD	_	_
7	c-Myc	_	NN	_	_	8	NMOD	_	_
8	binding	_	NN	_	_	5	VMOD	_	_
9	to	_	TO	_	_	8	NMOD	_	_
10	galectin-1	_	NN	_	_	11	NMOD	_	_
11	promoter	_	NN	_	_	9	PMOD	_	_
12	.	_	.	_	_	5	P	_	_
		
1	PTTG-induced	_	JJ	_	_	3	NMOD	_	_
2	galectin-1	_	NN	_	_	3	NMOD	_	_
3	transactivation	_	NN	_	_	6	VMOD	_	_
4	and	_	CC	_	_	3	COORD	_	_
5	expression	_	NN	_	_	4	CONJ	_	_
6	were	_	VBD	_	_	0	ROOT	_	_
7	mediated	_	VBN	_	_	6	VC	_	_
8	by	_	IN	_	_	7	VMOD	_	_
9	c-Myc	_	NN	_	_	8	PMOD	_	_
10	,	_	,	_	_	6	P	_	_
11	and	_	CC	_	_	6	COORD	_	_
12	both	_	DT	_	_	13	NMOD	_	_
13	inductions	_	NNS	_	_	14	VMOD	_	_
14	were	_	VBD	_	_	11	CONJ	_	_
15	suppressed	_	VBN	_	_	14	VC	_	_
16	by	_	IN	_	_	15	VMOD	_	_
17	c-Myc	_	NN	_	_	19	NMOD	_	_
18	RNAi	_	NN	_	_	19	NMOD	_	_
19	cotranfection	_	NN	_	_	16	PMOD	_	_
20	.	_	.	_	_	6	P	_	_
		
1	These	_	DT	_	_	2	NMOD	_	_
2	findings	_	NNS	_	_	3	VMOD	_	_
3	elucidate	_	VBP	_	_	0	ROOT	_	_
4	the	_	DT	_	_	6	NMOD	_	_
5	molecular	_	JJ	_	_	6	NMOD	_	_
6	mechanisms	_	NNS	_	_	3	VMOD	_	_
7	of	_	IN	_	_	6	NMOD	_	_
8	PTTG	_	NN	_	_	9	NMOD	_	_
9	overexpression	_	NN	_	_	7	PMOD	_	_
10	in	_	IN	_	_	6	NMOD	_	_
11	promoting	_	VBG	_	_	10	PMOD	_	_
12	tumor	_	NN	_	_	13	NMOD	_	_
13	metastasis	_	NN	_	_	11	VMOD	_	_
14	,	_	,	_	_	6	P	_	_
15	whereby	_	WRB	_	_	18	VMOD	_	_
16	up-regulated	_	JJ	_	_	17	NMOD	_	_
17	PTTG	_	NN	_	_	18	VMOD	_	_
18	modulates	_	VBZ	_	_	6	NMOD	_	_
19	expression	_	NN	_	_	18	VMOD	_	_
20	and	_	CC	_	_	19	COORD	_	_
21	secretion	_	NN	_	_	20	CONJ	_	_
22	of	_	IN	_	_	19	NMOD	_	_
23	metastasis-related	_	JJ	_	_	24	NMOD	_	_
24	factors	_	NNS	_	_	22	PMOD	_	_
25	to	_	TO	_	_	18	VMOD	_	_
26	facilitate	_	VB	_	_	25	IM	_	_
27	cell	_	NN	_	_	28	NMOD	_	_
28	motility	_	NN	_	_	26	VMOD	_	_
29	.	_	.	_	_	3	P	_	_
		
